Conforti, F., Holtschmidt, J., Nekljudova, V., Sala, I., Pagan, E., Solbach, C., . . . Loibl, S. (2025). Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: A pooled analysis of GBG and AGO-B Study Group trials. The lancet. Oncology, 26(12), . https://doi.org/10.1016/S1470-2045(25)00546-7
Chicago-Zitierstil (17. Ausg.)Conforti, Fabio, et al. "Distant Disease-free Survival as a Surrogate Endpoint for Overall Survival in Randomised Trials of Neoadjuvant Therapy for Early Breast Cancer: A Pooled Analysis of GBG and AGO-B Study Group Trials." The Lancet. Oncology 26, no. 12 (2025). https://doi.org/10.1016/S1470-2045(25)00546-7.
MLA-Zitierstil (9. Ausg.)Conforti, Fabio, et al. "Distant Disease-free Survival as a Surrogate Endpoint for Overall Survival in Randomised Trials of Neoadjuvant Therapy for Early Breast Cancer: A Pooled Analysis of GBG and AGO-B Study Group Trials." The Lancet. Oncology, vol. 26, no. 12, 2025, https://doi.org/10.1016/S1470-2045(25)00546-7.